Trial Profile
Significance of prognostic and predictive factors for the efficacy and safety of neoadjuvant chemotherapy in combination with chemoradiation administered in patients with locally advanced cervical cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Mar 2012
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Cervical cancer
- Focus Adverse reactions; Therapeutic Use
- 02 Aug 2011 New trial record